HLA-A*3303 and *3301 predispose patients to persistent hepatitis B infection

Amitis Ramezani; Arezoo Aghakhani; Ebrahim Kalantar; Mohammad Banifazl; Ali Eslamifar; Ali Akbar Velayati

HLA-A3303 and 3301 predispose patients to persistent hepatitis B infection

Authors

Amitis Ramezani Clinical Research Dept., Pasteur Institute of Iran, Tehran, Iran
Arezoo Aghakhani Clinical Research Dept., Pasteur Institute of Iran, Tehran, Iran
Ebrahim Kalantar School of Allied Medical Sciences, Iran Medical University, Tehran, Iran
Mohammad Banifazl Iranian Society for Support Patients with Infectious Disease, Tehran, Iran
Ali Eslamifar Clinical Research Dept., Pasteur Institute of Iran, Tehran, Iran
Ali Akbar Velayati Masih Daneshvari Hospital, Tehran, Iran

Keywords:

Abstract

Downloads

Published

2009-03-01

How to Cite

Ramezani A, Aghakhani A, Kalantar E, Banifazl M, Eslamifar A, Velayati AA. HLA-A*3303 and *3301 predispose patients to persistent hepatitis B infection. JGLD [Internet]. 2009 Mar. 1 [cited 2026 Jul. 21];18(1):117-24. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/2009.1.191